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Replication of vif- caprine arthritis encephalitis virus (CAEV) is highly attenuated in primary goat synovial membrane cells
and blood-derived macrophages compared to the wild-type (wt) virus. We investigated the requirement for CAEV Vif for in
vivo replication and pathogenicity in goats by intra-articular injection of either infectious proviral DNA or viral supernatants.
Wild-type CAEV DNA or virus inoculation induced persistent infection resulting in severe inflammatory arthritic lesions in
the joints. We were unable to detect any sign of virus replication in vif- CAEV DNA inoculated goats, while vif- CAEV virus
inoculation resulted in the seroconversion of the goats. However, virus isolation and RT-PCR analyses on blood-derived
macrophage cultures remained negative throughout the experiment as well as in joint or lymphoid tissues taken at necropsy.
No pathologic lesions could be observed in joint tissue sections examined at necropsy. Goats inoculated with the vif- virus
demonstrated no protection against a pathogenic virus challenge. These results demonstrate that CAEV Vif is absolutely
required for efficient in vivo virus replication and pathogenicity and provide additional evidence that live attenuated lentivi-
ruses have to establish a persistent infection to induce efficient protective immunity. q 1996 Academic Press, Inc.
INTRODUCTION 1993; Gibbs et al., 1995; Hoch et al., 1995) and/or with
vpx mutants of SIVmac239 (Gibbs et al., 1995) concluded
Caprine arthritis encephalitis virus (CAEV) is a member that these two genes are not required for pathogenicity.
of the lentivirus subfamily of retroviruses which also in- The vif gene is the only accessory gene conserved in
clude human (HIV-1 and HIV-2), simian (SIV), feline (FIV),
the genome of the small ruminant lentiviruses, visna vi-
and bovine (BIV) immunodeficiency viruses, equine infec-
rus, and CAEV (Sonigo et al., 1985; Saltarelli et al., 1990;
tious anemia virus (EIAV), and ovine visna virus (Narayan
Oberste and Gonda, 1992), suggesting that vif is im-
and Clements, 1990). These lentiviruses are character-
portant for natural infection. Recent reports demon-ized by the presence of a variable number of genes cod-
strated that Vif is essential in vitro to allow an efficienting for accessory proteins (vif, vpr, vpu, and nef in the
virus replication in primary lymphocytes infected withcase of HIV-1), in addition to the genes coding for the
HIV-1 and HIV-2 (Gabuzda et al., 1992, 1994; Michaelsstructural and the regulatory proteins (Cullen and
et al., 1993; Gibbs et al., 1994a; Courcoul et al., 1995),Greene, 1990). Understanding the role of the different
SIVmac239 (Gibbs et al., 1994b), and FIV (Shacklett andaccessory genes of HIV for in vivo replication and patho-
Luciw, 1994), or primary macrophages infected withgenesis requires studies of animal models using infec-
CAEV (Harmache et al., 1995a). In vivo studies on biologi-tious molecular clones deleted in one or several of these
cal or molecular clones isolated directly or after short-auxiliary genes. Among the animal models for evaluation
term culture of peripheral blood mononuclear cellsof HIV infection in vivo, infection of common rhesus mon-
(PBMCs) from HIV-1-infected patients revealed that thekeys with an infectious molecular clone of SIV (SIVmac239)
vif open reading frame was conserved with little variabil-results in AIDS-like disease similar to HIV-induced dis-
ity (Sakai et al., 1991; Groenink et al., 1992; Wieland etease in humans (Kestler et al., 1990). Infection of rhesus
al., 1994; Sova et al., 1995), suggesting that HIV-1 Vif ismonkeys with nef mutants of SIVmac239 revealed the cru-
required for infection in vivo.cial role of Nef in maintaining high virus load and patho-
The infection of goats with CAEV is a suitable animalgenic potential (Kestler et al., 1991; Daniel et al., 1992).
model with which to study the ability of deletion mutantsThe same kind of studies with vpr mutants (Lang et al.,
to establish persistent infection and pathogenesis. CAEV
causes chronic inflammatory disease in persistently in-
fected goats, resulting mainly in mastitis and arthritis1 Present address: University of Washington, School of Medicine,
Department of Microbiology, K-451 Health Sciences Center, Box (Narayan and Cork, 1985; Cheevers and McGuire, 1988).
357740, Seattle, WA 98195-7740. An infectious molecular clone was derived from the Cork2 To whom correspondence and reprint requests should be ad-
strain of CAEV (Pyper et al., 1986) and its sequence wasdressed. Fax: (33) 91 82 60 61: E-mail: msuzan@inserm-U372.univ-
mrs.fr. entirely determined (Saltarelli et al., 1990). Experimental
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infection of goats with this cloned virus reproduced the proviral DNA; goats 3, 21, 8, and 7 received 100 mg of
vif- CAEV proviral DNA; goats 153 and 15 were inoculatedcharacteristic features of the natural infection, i.e., persis-
tent infection and induction of inflammatory arthritic le- with 1 ml of wt CAEV viral supernatant containing about
50,000 cpm/ml of RT activity (positive control). Five adultsions in the joints (M. Suzan, unpublished results). We
recently described the successful infection of goats after goats were obtained from another CAEV-free breeding
(ENV, Lyon) and were injected in the right carpus with 1intra-articular inoculation of wild-type CAEV Cork strain
proviral DNA, and in the meantime, the accessory role ml of medium alone (goat 9315, negative control); 1 ml
of wt CAEV viral supernatant (goat 9317, positive control);of the CAEV tat gene for virus replication in vivo was
demonstrated (Harmache et al., 1995b). In this study, we 1 ml of vif- CAEV viral supernatant (goats 9316, 9322, and
9325). Each supernatant was diluted in order to obtain ainvestigated the importance of the CAEV vif gene in vivo
by intra-articular inoculation of goats with the vif deleted dose of 20,000 cpm/ml of RT activity. Challenge of this
second group of goats was performed on Day 228 postin-proviral DNA or vif deleted virus particles produced on
semipermissive primary synovial membrane cells. These oculation (p.i.) by injecting, in the opposite carpus (left
carpus), 1 ml of wt CAEV viral supernatant containingexperiments established the necessary requirement for
a functional CAEV vif gene in order to induce infection about 90,000 cpm/ml of RT activity. Goat 9325 was chal-
lenged with 1 ml of medium alone. At Day 83 postchal-and pathogenesis.
lenge (pc), goats were necropsied and samples from
different tissues and lymphoid organs were taken andMATERIALS AND METHODS
processed for different purposes: synovial membranes
CAEV molecular clones were either frozen in liquid nitrogen for histological exam-
ination of tissue sections after hematoxylin/eosin stain-Ligation of two HindIII fragments, prepared from the
ing or put into culture for virus isolation and RT-PCR9- and 0.5-kb HindIII clones, was necessary to generate
analyses. RNA was directly extracted from samples ofa full-length wild-type (wt) infectious molecular clone
bone marrow and prescapular and retro-mammary lymph(Pyper et al., 1986; Saltarelli et al., 1990). The vif- CAEV
nodes for RT-PCR analyses.infectious molecular clone used in this study was ob-
Blood samples were taken at regular intervals to deter-tained in the same way using the CAEV vif D2 9-kb
mine the serological status of the animals and to isolateHindIII clone previously described (Harmache et al.,
PBMCs-derived macrophages for virus isolation and RT-1995a), which harbors a 276-bp deletion in the vif gene
PCR analyses.and has the capacity to encode for the 27 N-terminal
amino acids of Vif.
PCR and RT-PCR analyses
Cells
Total cellular DNA was prepared with the nucleic acid
Primary goat synovial membrane (CFSM1) cells were extraction kit Isoquick (Microprobe), according to the
derived from carpal joints and maintained in culture in manufacturer’s protocol. Total cellular RNA was double
Eagle’s minimal essential medium (MEM) containing 1% extracted using the RNAzol (Bioprobe) reagent and proto-
glutamine, penicillin, streptomycin, and 10% fetal calf se- col. PCR and RT-PCR analyses as well as Southern blot
rum. Peripheral blood mononuclear cells (PBMCs) were hybridization of the amplified products were performed
isolated on Ficoll-Paque density gradients (Pharmacia) under the same conditions as previously described (Har-
and either processed directly or cultured for 10–12 days mache et al., 1995a). The sequences and positions of
in Teflon bags to allow macrophage differentiation and the primers used are as follows, according to Saltarelli
maturation in RPMI 1640 medium supplemented with 1% et al. (1990): POL S (sense primer), 5*-GATAGGATAGGA-
glutamine, penicillin, streptomycin, 10 mM HEPES (N- GTGCATTG-3* (3721 to 3740); POL H (hybridization oligo-
2-hydroxyethylpiperazine-N*-2-ethanesulfonic acid), 1005 nucleotide), 5*-TATTTCCGAAATATATTTGTC-3* (3801 to
M b-mercaptoethanol, and 10% sheep serum. Transfec- 3781); POL A (antisense primer), 5*-TGAGTCTATGAT-
tion of CFSM1 cells with the Lipofectin reagent and RT TCCTCCT-3* (4020 to 4002); VIF1 (sense primer), 5*-CAG-
activity measurement in 100-fold concentrated cell-free GATCCATGCAAAATTCATCCCGCC-3* (5006 to 5024),
culture supernatants were previously described (Har- VIF2 (hybridization oligonucleotide), 5*-GGTAATTCT-
mache et al., 1995a). GGTCCAGGT-3* (5067 to 5050), VIF7 (antisense primer),
5*-CAGGATCCCTTTGAGGCAGTTCTTCAC-3* (5710 toIn vivo experimentation
5692).
Specific primers were chosen to amplify the caprineTen 9- to 10-month-old goats were obtained from a
single CAEV-free breeding (CNEVA Sophia Antipolis) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
as an internal control of the PCRs and RT-PCRs. Theywere inoculated in the left carpus with 1 ml of a mixture of
DNA and cationic lipids (DOTAP, Boehringer-Mannheim). are as follows, according to the partial caprine GAPDH
sequence (G. Que´rat, unpublished results): CGAP1Goats 13 and 14 received 100 mg of pRC-CMV DNA (neg-
ative control); goats 9 and 18 received 100 mg of wt CAEV (sense primer), 5*-GTTCCACTATGATTCCACCC-3* (25-
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44); CGAP2 (hybridization oligonucleotide), 5*-CAGTCA-
AGGCAAGAGAATGGG-3* (63-82); CGAPR1 (antisense
primer), 5*-TCCCTCCACGATGCCAAA-3* (406-386).
ELISA and Western blot analyses
ELISA was performed with the Chekit CAEV/MVV test
(Behring) against total viral proteins. Results are ex-
pressed as the percentage of positive controls estab-
lished with the formula: (mean tests 0 mean negative
controls)/(mean positive controls 0 mean negative con-
trols) 1 100. According to the manufacturer’s instruc-
tions, sera with percentages below 30% were considered
negative, doubtful when between 30 and 40%, and posi-
tive above 40%.
Western blot analysis was performed on viral proteins
prepared from sucrose gradient purified virus, separated
by electrophoresis on a 12% polyacrylamide–SDS gel,
and blotted on nitrocellulose. Sera were tested at a
1/100 dilution and the reaction was revealed with rabbit
FIG. 1. RT activity measurement in the cell-free supernatants fromanti-goat immunoglobulins coupled to peroxidase (Nor-
CFSM1 cells transfected with plasmid DNA (mock), wt or vif- CAEVdic), 1/1000 dilution, and 3,3-diaminobenzidine (Sigma)
DNA. The medium was changed every 3–4 days and RT activity mea-as substrate.
sured in 1 ml of supernatant 100-fold concentrated.
RESULTS
by ELISA or Western blot assays in the sera or the syno-In vivo inoculation of vif- CAEV proviral DNA is unable
vial fluids of the four goats inoculated with the vif- CAEVto induce infection
DNA throughout the experiment. Viral sequences detec-
tion was performed by PCR analyses through five toIn order to investigate the importance of the CAEV vif
seven tests over the 3- to 4-month period of experiment,gene for virus replication in vivo, we chose to inoculate
and was positive, at different time points, only on DNAgoats with the infectious proviral wild-type DNA (wt CAEV
extracted from PBMCs isolated from wt CAEV viral super-DNA) or DNA deleted in the vif gene (vif- CAEV DNA).
natant or proviral DNA injected animals. These resultsAs the generation of an infectious molecular clone of
were confirmed by the analyses performed on the syno-CAEV needs the ligation of two HindIII fragments, as
vial membranes taken at necropsy 3 to 4 months afterdescribed under Materials and Methods, part of each
inoculation.DNA preparation (5 mg) used for in vivo injection was
Part of the membranes were put into culture for virustested by in vitro transfection of primary goat synovial
detection by RT activity measurement into the cell-freemembrane (CFSM1) cells to ensure ligation efficiency.
culture supernatants and RT-PCR analyses after RNAFigure 1 shows the replication profile monitored by RT
extraction (Table 1). Negative control goats 13 and 14activity measurement in the cell-free supernatants of the
which received plasmid DNA produced negative resultstransfected CFSM1 cells. As expected, the vif- virus has
with all these tests. Virus could be isolated by the twoa very low and slow replication compared to the wild-
techniques, from the synovial membrane cell cultures oftype virus, corresponding to the attenuated phenotype
the wt CAEV DNA inoculated goats 9 and 18. Interest-previously described (Harmache et al., 1995a). The corre-
ingly, synovial membranes from both joints were positivesponding proviral DNAs were then mixed with an equal
for goat 9, whereas only the left synovial membrane wasvolume of cationic lipids and inoculated into goats. Each
positive for goat 18, suggesting that in one case, a sys-animal received a single intra-articular injection in the
temic infection was established allowing virus detectionleft carpus of 100 mg of pRC-CMV DNA (goats 13 and
in the joint opposite to the inoculation site. Virus isolation14), wt CAEV DNA (goats 9 and 18), or vif- CAEV DNA
was negative for the three vif- CAEV DNA inoculated(goats 3, 21, 8, and 7). As positive controls of infection,
goats tested (3, 8, and 7). RT-PCR analysis using primerstwo goats were inoculated by the same route with wt
allowing detection of the spliced rev mRNA showed aCAEV viral supernatant (goats 153 and 15). Results of this
positive signal only for RNA extracted from synovial mem-experiment are summarized in Table 1. Seroconversion
brane cells of goats 9 and 18 (wt CAEV DNA). Anotherdetermined by ELISA was observed in goats injected
part of the different synovial membranes was frozen andwith the wt CAEV viral supernatant or proviral DNA at
tissue sections were examined for the presence of in-Day 26 p.i. (goats 153 and 15) and Day 49 p.i. (goats 9
and 18), respectively. No antibodies were detected either flammatory lesions after hematoxylin/eosin staining.
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TABLE 1
Experimental Infection of Goats by Intra-articular Inoculation of wt or vif- CAEV Proviral DNA or Viral Supernatants
Inoculationa
wt CAEV viral wt CAEV
Plasmid DNA supernatant proviral DNA vif- CAEV proviral DNA
Animal No. 13 14 153 15 9 18 3 21 8 7
ELISAb
Serum 0 0 / / / / 0 0 0 0
Synovial fluid 0 0 / / / / 0 0 0 0
Western blotc
Serum 0 0 / / / / 0 0 0 0
Synovial fluid 0 0 / / / / 0 0 0 0
Virus detection in PBMCs
PCRd 0 0 / / / / 0 0 0 0
Virus detection in synovial
membrane cells
RT activitye 0 NT NT NT / / 0 NT 0 0
RT-PCR NT 0 NT NT / / 0 NT 0 0
a Each goat received a single intra-articular inoculation in the left carpus of either 100 mg DNA complexed to cationic lipids or 1 ml of wt viral
supernatant (50,000 RT cpm).
b Seroconversion was determined by ELISA using a commercial kit (Behring). Values 40% above positive control were scored as positive (/) and
otherwise considered negative (0).
c Western blot assays were performed on total viral proteins separated on a 12% polyacrylamide–SDS gel. Sera or synovial fluids were tested
at a 1:100 dilution. (/) denotes the presence of antibodies against Gag and Env proteins; (0) indicates that no specific bands were observed.
d DNA was extracted from 107 freshly isolated PBMCs and submitted to PCR amplification using either pol (POLS/POLA)- or vif-specific primers
(VIF1/VIF7).
e Part of the synovial membranes taken at necropsy were put into culture. Virus detection was performed by direct isolation from culture
supernatants (RT activity) or by RT-PCR analyses after RNA extraction, using primers specific for the spliced rev mRNA. NT, not tested.
Characteristic pictures of tissue sections from goats 13 positive control) or Day 28 p.i. (9316, 9322, and 9325).
(negative control), 9 (wt CAEV DNA), and 3 (vif- CAEV The vif- virus inoculated goat 9325 exhibited the highest
DNA) are shown in Fig. 2. While the synovial membranes level of antibody response, equivalent to the positive con-
of goats 13 and 3 presented a normal aspect (Figs. 2a trol goat 9317, and, although the level decreased, it re-
and 2c, respectively), severe inflammatory lesions could mained positive until Day 221 p.i. Sera titers from the
be observed in tissue sections from goat 9 (Fig. 2b), two other vif- virus injected goats, 9316 and 9322,
with extensive mononuclear cell infiltration comprising dropped below the limit of positivity from Day 102 p.i. In
plasmocytes. order to compare the reactivity profile of these antibodies
against the different viral proteins, sera at Day 7 and Day
vif- virus is able to induce seroconversion but not 221 p.i. were analyzed in Western blot assays (Fig. 4).
persistent infection of goats All sera taken at Day 7 p.i. showed no specific bands
(lanes 1, 4, 7, 10, and 13) as did serum from goat 9315In this experiment, goats received a single intra-articu-
at Day 221 p.i. (lane 2) and negative control serum (lanelar injection in the right carpus of 1 ml of viral superna-
0C). Sera from inoculated goats revealed different pat-tants, each containing 20,000 cpm/ml of RT activity, corre-
terns of reactivity at Day 221 p.i.: The positive controlsponding to 3.3 1 104 TCID50 for the wt virus and 5 1
goat 9317 (lane 5) developed antibodies against all the103 TCID50 for the vif- virus. Although not identical, the
major forms of Gag proteins, either precursors (Pr55gag,number of infectious particles injected into goats was
Pr48gag, Pr38gag) or mature forms (p28, p18, and p14.5),above the goat infectious dose (M. Suzan et al., unpub-
as in positive control serum (lane /C). Anti-p28 antibod-lished results). One negative control goat, 9315, was in-
ies could be observed in sera from vif- virus injectedjected with 1 ml of culture medium, the positive control
goats whereas antibodies against the precursor formsgoat, 9317, was inoculated with wt virus supernatant, and
of Gag could not be detected (lanes 8, 11, and 14). Anti-three goats, 9316, 9322, and 9325, received vif- virus
p18 antibodies were weakly detected in sera from goatsupernatant. The follow-up of the antibody response de-
9316 (lane 8). Anti-p14.5 antibodies were present in seratermined by ELISA against total viral proteins is shown
from goat 9316 (lane 8) and 9325 (lane 14) but not inin Fig. 3. Sera with values above 40% of the positive
serum from goat 9322 (lane 11). Under our test condi-control were considered positive. All the animals, except
the negative control 9315, seroconverted at Day 21 (9317, tions, it was not possible to detect the envelope proteins.
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FIG. 2. Histopathology of the synovial membranes of negative control goat (a) or after wt (b) or vif- (c) proviral DNA intra-articular inoculation.
Synovial membranes samples were taken at necropsy and frozen sections were stained with hematoxilin/eosin.
Virus isolation was possible by monitoring RT activity vif- CAEV inoculated goats are not protected against
in the culture supernatants of blood-derived macro- a pathogenic challenge
phages taken at Weeks 4 and 11 p.i. from the positive
Challenge was performed at Week 32 p.i. by intra-control goat 9317 and became negative thereafter. Virus
articular injection in the left carpus of 1 ml of wt virusisolation was negative for each vif- virus inoculated goat
supernatant, equivalent to 90,000 cpm/ml of RT activity.in all the assays. Since only a small percentage of blood
The vif- virus injected goat 9325 received 1 ml of mediummonocytes/macrophages are infected by CAEV (Narayan
alone (inoculated control). Goat C70 was a naive animalet al., 1983; Gendelman et al., 1986) and since direct virus
that was included in the experimental group the day ofisolation from cultured macrophages is not a sufficiently
challenge as a positive control of infection and thus re-sensitive technique, we performed virus detection by RT-
ceived only the challenge dose. The serological statusPCR. Results are summarized in Table 2. Over the 31-
of the animals was determined by ELISA at Day 83 post-week period before challenge, seven RT-PCR assays
challenge (pc, Fig. 3). Goat 9317 as well as goats 9316were performed on RNA extracted from blood-derived
and 9322 (inoculated challenged) exhibited ELISA valuesmacrophages. A positive signal could transiently be ob-
higher than those determined at Day 221 p.i., indicatingserved in samples from the wt immunized 9317 goat at
efficient stimulation of the immune system, as was alsoWeeks 2, 4, and 11, whereas virus detection in the vif-
the case for goats 9315 (mock inoculated challenged)CAEV inoculated goats, 9316, 9322, and 9325, remained
and C70 (uninoculated challenged). The inoculated con-negative. As a control, amplification of the housekeeping
trol goat 9325 was still positive but with a decreasedgene GAPDH provided the same intensity signal in each
sample (data not shown). ELISA value. The Western blot profile of these sera was
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FIG. 3. Follow-up of the antibody response after wt or vif- virus inoculation and pathogenic challenge. Goats received at Day 0 one intra-articular
injection of 1 ml of medium (9315), wt (9317), or vif- (9316, 9322, 9325) viral supernatants. Challenge was performed at Day 228 with wt virus, except
for goat 9325. Goat C70 was inoculated at Day 228, as a positive control of challenge. Sera were taken at the indicated time points postinoculation
and at Day 83 postchallenge (pc). They were considered positive when the ELISA value was 40% above that of the positive control.
determined (Fig. 4). All the sera presented a similar and times pc for the five wt challenged goats (data not shown
for goat C70), either by direct isolation from blood-derivedcomplete pattern of reactivity against the Gag proteins
(lanes 3, 6, 9, and 12), as described above. The vif- virus macrophages or by RT-PCR on macrophage RNA, while
the mock challenged goat 9325 was negative (Table 2).infected mock challenged goat 9325 only showed anti-
bodies against p28 and p14.5 (lane 15). This detection was transient since all the samples were
negative at week 12 pc, when the animals were necrop-Challenge virus detection was positive at different
FIG. 4. Western blot analysis of the antibody response pattern after wt or vif- virus injection and after virulent challenge. Sera were taken at Day
7 (lanes 1, 4, 7, 10, and 13), Day 221 p.i. (lanes 2, 5, 8, 11, and 14), or Day 83 postchallenge (3, 6, 9, 12, and 15). All the animals were challenged,
except goat 9325. /C, positive control serum; 0C, negative control serum. Molecular weight markers are indicated on the left.
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TABLE 2
Virus Detection by RT-PCR from Blood-Derived Macrophages of Goats Inoculated
with wt or vif- CAEV before and after Challenge with Pathogenic CAEV
Animal p. i 32 34 36 38 39 40 44
Group No. p.c. 1 2 4 6 11 14 31 0 2 4 6 7 8 12
Mock inoculated/wt
challenged 9315 0 0 0 0 0 0 0 0 NT / / / 0 0
Inoculated control
vif-/mock 9325 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inoculated challenged
wt/wt 9317 0 / / NT / 0 0 0 / NT / / / 0
vif-/wt 9316 0 0 0 0 0 0 0 0 / NT / 0 / 0
vif-/wt 9322 0 0 0 0 0 0 0 0 / / / / / 0
RT-PCR analysis on blood derived macrophages taken at different weeks postinoculation (p.i.) or postchallenge (pc, boldface entries). RNA was
extracted from blood derived macrophages after 10 days of culture in Teflon bags. RT products were submitted to PCR amplification with the pol-
or vif- specific primers (POLS/POLA or VIF1/VIF7). Southern blots of the amplified products were hybridized with the 32-P-labeled POLH or VIF2
oligonucleotide probe. NT, not tested.
sied. We already observed this transient virus detection Tissue sections from the frozen part of the synovial
membranes were examined for the presence of histologi-after CAEV wt inoculation of goat 9317 and in several
other in vivo experimental CAEV infections (Harmache et cal lesions after hematoxylin/eosin staining (Fig. 6). As
already observed in the first experiment of this studyal., unpublished results). Different tissue samples were
taken at necropsy and analyzed by RT-PCR after direct (Figs. 2a and 2c), synovial membranes from mock or vif-
virus infected goat 9325 were normal (Figs. 6a and 6c).RNA extraction. Southern blot of the products amplified
with the pol- specific primers (POLS/POLA) was hybrid- Severe inflammatory lesions with massive infiltration of
macrophages and lymphocytes were observed in jointsized with a 32P-labeled internal oligonucleotide probe
(POLH). Results are shown in Fig. 5. Except for the right of the mock infected, wt virus challenged goat 9315 (Fig.
6b) and goat 9317 (not shown), whereas joints from vif-synovial membrane sample of goat 9316 (lane c), chal-
lenge virus could be detected in any of the tissue tested, virus infected, wt virus challenged goats developed le-
sions but to a somewhat lesser extent, as shown by ai.e., left (lanes a) or right (lanes c) synovial membranes,
bone marrow (lanes b), left (lanes d) or right (lanes e) representative picture in Fig. 6d.
retro-mammary lymph nodes, and left (lanes f) or right
(lanes j) prescapular lymph nodes. Once again, samples DISCUSSION
from the vif- virus infected, mock challenged goat 9325
produced only negative signals, whereas the internal The CAEV vif- virus has been proven able to replicate
in vitro in primary synovial membrane cell cultures andcontrol GAPDH was positive.
FIG. 5. Challenge virus detection by RT-PCR analysis on different tissues taken at necropsy. RNA was directly extracted from tissue samples
and RT products were submitted to PCR amplification using the pol-specific primers (POLS/POLA). Southern blot of the amplified products was
hybridized with the 32P-labeled POLH oligonucleotide probe. Amplification of GAPDH mRNA was used as an internal control. Tissues analyzed were
synovial membranes from the left (a) or right (c) joint; bone marrow (b); left (d) or right (e) retro-mammary lymph node; and left (f) or right (j)
prescapular lymph node.
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FIG. 6. Histology of synovial membranes from a mock infected goat (a), mock infected, wt challenged goat (b), vif- virus inoculated goat (c), and
vif- virus injected, wt challenged goat (d). Sections were prepared as in Fig. 2.
primary blood derived macrophages, with an attenuated of viral infectivity of genetic mutants of BLV has also
been reported (Willems et al., 1993). We previously dem-phenotype compared to the wt virus (Harmache et al.,
1995a). These cells represent the natural target cells for onstrated that inoculation into goats of proviral DNA from
the wt or tat deleted infectious molecular clone of CAEVCAEV infection in vivo (Klevjer-Anderson and Anderson,
1982; Narayan et al., 1983). This paper reports the neces- resulted in persistent infection and disease progression
(Harmache et al., 1995b). The same approach was thussary requirement for a functional vif gene of the lentivirus
CAEV for in vivo induction of persistent infection and used to study the impact of the vif gene deletion on virus
replication in vivo. No evidence of virus replication couldpathogenesis. Infectious molecular clones of lentiviruses
are important tools for determining the role of the so- be obtained by different techniques (ELISA, virus isola-
tion, PCR, and RT-PCR), in goats inoculated with the vif-called ‘‘nonessential’’ genes in the molecular mecha-
nisms of pathogenesis, but also for therapy development proviral DNA whereas inoculation of the wt proviral DNA
established infection leading to the induction of inflam-and vaccine research (Desrosiers, 1992; Gibbs et al.,
1994a, 1994b). Demonstration that an infectious molecu- matory lesions in the joints. These results demonstrated
that in vivo replication of CAEV was impaired as a resultlar clone of SIVmac could induce an AIDS-like disease
in rhesus monkeys (Kestler et al., 1990) as well as subse- of the vif gene deletion; thus, experimental CAEV infec-
tion is a relevant animal model for the understandingquent studies in vivo using nonessential gene-deletion
mutants of this clone (Lang et al., 1993; Gibbs et al., 1995; of the contribution of different genes to infection and
pathogenesis. Because DNA inoculation in the presenceHoch et al., 1995) provided new insights into the relative
importance of such genes in virus replication, persis- of cationic lipids could be considered an in vivo transfec-
tion, without any cell targeting specificity, we performedtence, and pathogenesis.
Some reports described the successful infection of a second in vivo experiment in which goats received
intra-articular injection of CAEV vif- viral supernatants inanimals upon injection of proviral DNA from different re-
troviruses such as SIVmac (Letvin et al., 1991) or bovine order to increase the percentage of infected specific tar-
get cells. Virus isolation as well as RT-PCR analysesleukemia virus (Willems et al., 1992), and the in vivo study
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produced only negative results during the time course vif- virus inoculated goats were not protected against the
virulent challenge, indicating that the induced antibodyof the experiment, whereas CAEV wt inoculated goats
were transiently positive by these assays. These tran- response is not involved in protective immunity. By com-
parison, in vivo experiments using proviral DNA or virussient virus isolations are not the sign of a cleared infec-
tion since the animals developed inflammatory lesions inoculation of tat- CAEV revealed that this attenuated
deletion mutant was able to induce some protective ef-in the joints and RT-PCR analyses of different lymphoid
tissues at necropsy allowed virus detection (see also fect against pathogenic challenge (Harmache et al., 1996,
and manuscript in preparation). These results could beHarmache et al., 1996). Most probably they reflect a low
viral load in the monocytic compartment at the blood put together with those reported in the SIVmac model in
which the resistance to challenge infection was inverselylevel. The only evidence of virus expression in vif- virus
inoculated goats was provided by the seroconversion as related to the degree of attenuation of the immunizing
clone (Lohman et al., 1994; Denesvre et al., 1995). Dele-detected by ELISA, indicating that enough viral proteins
were expressed to stimulate the antibody response. We tion of the vif gene in the CAEV genome generates very
attenuated virus particles, unable to persistently replicateobserved that sera from vif- virus inoculated goats con-
tained antibodies directed mainly against two of the ma- in vivo and thereby unable to induce an efficient stimula-
tion of the host immune response conferring protectiveture forms of the Gag protein, p28 and p14.5, whereas
the p18 and the precursor forms were additionally de- immunity.
tected by sera from wt CAEV infected goats. Goat 9325
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